Sum of the parts: Ensuring a resilient global drug supply chain

Suda, Katie J.; Tadrous, Mina

doi:10.1017/ice.2021.138

Cited by 8 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We can talk about the resistance of food chains [7] of the blood transport supply chains [8] or resistance in the process of drug transport [9]. Each of these chains have their own character.…”

Section: Literature Reviewmentioning

confidence: 99%

Building Resilience Attributes of Supply Chains from the Perspective of their Types

Maryniak

2022

Management Systems in Production Engineering

View full text Add to dashboard Cite

We are currently dealing with disruptions in supply chains. They come from faulty production systems, in poor organization of distribution processes or are related to external factors, often unseen. Consequently, it is necessary to build resistant chains. This article discusses this topic in the context of the basic types of supply chains, i.e. agile, lean and green. The aim of the study was to assess the types of chains in which the tested production entities are embedded and check if the proposed models of building resilience take this into account. The reason this should be investigated further, is to indicate relationships in areas that are rarely captured in research models. Both quantitative and qualitative methods were used in the work. Interviews were conducted in over seventy subjects and a critical analysis of the literature on model of resilient supply chains was performed. As a result of the work undertaken, it can be concluded, inter alia, that in the economic reality, there are hybrid chains in which the characteristics of pro-saving chains prevail. It was also established that the proposed research models for resilient chains should take into account, to greater extent, accents compatible with the nature of the chains occurring an economic reality. It is also necessary to extend their content to include pro-environmental components. At the same time, it is not unequivocal that the chains with the advantage of agility-related attributes are more resistant than the chains in which the greater concentration is attributed to the attributes of lean or green chains. Determining this requires further research.

show abstract

Section: Literature Reviewmentioning

confidence: 99%

Building Resilience Attributes of Supply Chains from the Perspective of their Types

Maryniak

2022

Management Systems in Production Engineering

View full text Add to dashboard Cite

show abstract

“…16 Demand for drugs was severely affected, and pharmaceutical shortages shed light on the flaws in the global supply chain that could compromise the response to new waves of COVID-19 and other pandemics. 17 In the context of a public health emergency, governments and international organisations are faced with a series of challenges, including supply chain and logistics associated with safe storage, deployment, administration and disposal of vaccines. 18 The impact of the COVID-19 pandemic on the fragility of the global vaccine supply chain in responding to a pandemic is yet to be unravelled with real-world data.…”

Section: Bmj Global Healthmentioning

confidence: 99%

“…As a result of flight cancellations, border closures and transport disruptions, countries’ and suppliers’ shipment plans were significantly impacted 16. Demand for drugs was severely affected, and pharmaceutical shortages shed light on the flaws in the global supply chain that could compromise the response to new waves of COVID-19 and other pandemics 17. In the context of a public health emergency, governments and international organisations are faced with a series of challenges, including supply chain and logistics associated with safe storage, deployment, administration and disposal of vaccines 18…”

Section: Introductionmentioning

confidence: 99%

Mapping global trends in vaccine sales before and during the first wave of the COVID-19 pandemic: a cross-sectional time-series analysis

et al. 2021

Self Cite

View full text Add to dashboard Cite

BackgroundWhile the COVID-19 pandemic may have substantially hindered the provision of routine immunisation services worldwide, we have little data on the impact of the pandemic on vaccine supply chains.MethodsWe used time-series analysis to examine global trends in vaccine sales for a total of 34 vaccines and combination vaccines using data from the IQVIA MIDAS Database between August 2014 and August 2020 across 84 countries. We grouped countries into three income-level categories, and we modelled the changes in vaccine sales from April to August 2020 versus April to August 2019 using autoregressive integrated moving average models.ResultsIn March 2020, global sales of vaccines dropped from 1211.1 per 100 000 to 806.2 per 100 000 population in April 2020, an overall decrease of 33.4%; however, the vaccine sales interruptions recovered disproportionately across economies. Between April 2020 and August 2020, we found a significant decrease of 20.6% (p<0.001) in vaccine sales across high-income countries (HICs), in contrast with a significant increase of 10.7% (p<0.001) across lower middle-income countries (LMICs), relative to the same period in 2019. From August 2014 through August 2020, monthly per capita vaccine sales across HICs remained, on average, at least four times higher than in LMICs and nearly three times higher than in upper middle-income countries.ConclusionOur study revealed the heterogeneous impact of COVID-19 on vaccine sales across economies while underlining the substantial consistent disparities in per capita vaccine sales before and during the first wave of the COVID-19 pandemic. Action to ensure equitable distribution of vaccines is needed.

show abstract